Gujarat Themis Biosyn Ltd

NSE: GUJTHEM · BSE: 506879 · Pharmaceuticals & Biotechnology · 72 announcements

Share price: ₹391.45
Market cap: ₹5,095 Cr
Revenue (annual): ₹165.8 Cr
Net profit (annual): ₹46.68 Cr
P/E (TTM): 104.6×Sector 43.8×
Promoter holding: 59.33%-11.53% QoQ
FII holding: 3.80%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Preferential Issue 1 Other Announcement 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

4 Nov 2026 17:41 IST NSE

Preferential Issue

Gujarat Themis Biosyn Preferential Issue

Gujarat Themis Biosyn clarified its preferential issue of up to 82,10,786 shares at Rs 408. The filing covers utilisation timelines, allottee beneficial owners and a PCS certificate.

Value: ₹3,350 Cr

Open announcement → Read the filing ↗

27 Oct 2026 12:24 IST BSE

Board Meeting Date

Gujarat Themis Biosyn Board Meeting Date

Gujarat Themis Biosyn scheduled its board meeting for 4 Nov 2026 to approve Q2 and H2 un-audited results. No financial figures are disclosed in this advance intimation.

Open announcement → Read the filing ↗

23 Oct 2026 12:12 IST NSE

Other Announcement

Gujarat Themis Biosyn Other Announcement

Gujarat Themis Biosyn clarified that its 9 October 2026 credit-rating intimation was uploaded in error and should be disregarded. No substantive business event is reported.

Open announcement → Read the filing ↗